---
title: "Telix Pharmaceuticals Boosts CEO Remuneration Amid Growth"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/223510868.md"
description: "Telix Pharmaceuticals Ltd. has announced an increase in the remuneration package for its Managing Director and CEO, Dr. Christian Behrenbruch, effective January 2025. This decision reflects the company's growth and aims to align with competitive global market standards, suggesting a positive outlook for Telix in the biopharmaceutical sector."
datetime: "2024-12-29T21:58:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/223510868.md)
  - [en](https://longbridge.com/en/news/223510868.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/223510868.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/223510868.md) | [繁體中文](https://longbridge.com/zh-HK/news/223510868.md)


# Telix Pharmaceuticals Boosts CEO Remuneration Amid Growth

Telix Pharmaceuticals Ltd. (**AU:TLX**) has released an update.

### Don't Miss Our New Year's Offers:

-   Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
-   Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter

Telix Pharmaceuticals announced a raise in the remuneration package for its Managing Director and CEO, Dr. Christian Behrenbruch, starting January 2025. This increase aligns with the company’s growth and aims to match competitive global market standards. Investors may find this move indicative of Telix’s positive trajectory in the biopharmaceutical industry.

For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.

## Trending Articles:

-   ‘Hang on Tight,’ Says Top Investor About Apple Stock
-   ‘The Superior Choice,’ Says Top Investor About IONQ Stock
-   ‘Keep On Buying,’ Says Investor About Microsoft Stock

### 相关股票

- [Telix Pharmaceuticals (TLX.US)](https://longbridge.com/zh-CN/quote/TLX.US.md)
- [Argent Mid Cap ETF (AMID.US)](https://longbridge.com/zh-CN/quote/AMID.US.md)
- [GRANDPHARMA (00512.HK)](https://longbridge.com/zh-CN/quote/00512.HK.md)
- [Align (ALGN.US)](https://longbridge.com/zh-CN/quote/ALGN.US.md)

## 相关资讯与研究

- [Telix Pharmaceuticals Eyes 2026 Revenue Near $970M, Highlights PSMA Imaging Growth and Phase III Catalysts](https://longbridge.com/zh-CN/news/280059757.md)
- [Telix Resubmits NDA For Brain Cancer Imaging Candidate TLX101-Px To FDA](https://longbridge.com/zh-CN/news/279240678.md)
- [Here's How Much $100 Invested In abrdn Physical Silver Shares ETF 10 Years Ago Would Be Worth Today](https://longbridge.com/zh-CN/news/281394387.md)
- [BREAKINGVIEWS-SpaceX IPO will gauge market moxie more than depth](https://longbridge.com/zh-CN/news/281406751.md)
- [Palantir vs. Oracle: 1 AI Stock Looks Cheap](https://longbridge.com/zh-CN/news/281400403.md)